man die Situation nicht umschreiben:
Europe's COVID vaccine fiasco continues
... The vaccine rollout in France has been badly managed, he said,
... “The French are fed up,” and if the current four-week lockdown doesn’t lift in May as scheduled, he fears “another revolution.”
... Compounding Europe’s vaccine supply issues is the fact that the AstraZeneca shot — use of which was temporarily suspended last month by a dozen countries out of fears it might be linked to blood clots — is once again in limbo.
.., On Wednesday, however, the EMA walked back that news, stressing again that the benefits outweigh the risks.
... AstraZeneca vaccine as of mid-March, the agency said 84 had developed blood clots resulting in 18 deaths. Those numbers were enough, however, to convince the British health agency to issue recommendations Wednesday to stop using the vaccine for those under 30 years of age, and for AstraZeneca to put the brakes on clinical studies of the vaccine on children.
... At the same time, the European Commission, which oversees vaccine purchases for the EU, is dismayed that while AstraZeneca has not delivered its promised shipments to the bloc, some 77 million doses of vaccines manufactured in Europe were being shipped off to other countries, including to Britain, where 48 percent of the population has already received at least one shot of a vaccine. At one point last week, the European Commission threatened to block exports of all AstraZeneca doses until the company made good on its promised deliveries.
... Unhappy with the amount of vaccine allotted to Austria, that country’s Chancellor Sebastian Kurz last week threatened to block the European Commission from buying an additional 100 million doses of the Pfizer-BioNTech vaccine — ultimately dropping that idea and announcing that he was instead negotiating the purchase of a million doses of the Russian vaccine that hasn’t been approved for use in the EU.
... French President Emmanuel Macron and German Chancellor Angela Merkel also placed a joint call last week to Russian President Vladimir Putin during which they discussed the possibility of purchasing his shot.
... But Russia’s Sputnik V vaccine, which is currently employed in several Eastern European immunization programs despite not yet being green-lit by the European Medicines Agency,
... The Lancet, the highly respected medical journal, reported in February that the Sputnik inoculation has efficacy rates of 91 percent, but Slovakia’s national health agency is currently refusing to authorize Sputnik’s use there, saying that the vaccine delivered this week is not the same vaccine studied by the Lancet.
... What’s more, as he told Le Parisien, he expects Europe "will become the world's leading vaccine producer by the end of the year, with a volume that could reach 3 billion doses per year, compared to 2 billion for the US."
... This is a propaganda coup for Russia in trying to split the EU — by demonstrating that the EU is not able to take care of its population,” said Jamie Shea, senior fellow at the Brussels-based think tank Friends of Europe and a former deputy assistant secretary general for emerging security challenges of NATO. He added that given the relatively small production of the Sputnik vaccine and its limited use in Europe, that “the coup is disproportionate to the actual role that it’s really playing.”
https://www.google.com/amp/s/news.yahoo.com/...RFYYkrqZcffQF1R45Xw18Q
|
Thread abonnieren
